Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes

The survival of patients with metastatic breast cancer (MBC) has not improved, despite recent advances in therapeutic strategies. This is mainly due to the fact that cytotoxic agents cannot be administered over a long period, even if they exhibit favorable activity, due to treatment-related side eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: KONTANI, KEIICHI, HASHIMOTO, SHIN-ICHIRO, MURAZAWA, CHISA, NORIMURA, SHOKO, TANAKA, HIROAKI, OHTANI, MASAHIRO, FUJIWARA-HONJO, NAOMI, DATE, MANABU, TERAMOTO, KOJI, HOUCHI, HITOSHI, YOKOMISE, HIROYASU
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887815/
https://ncbi.nlm.nih.gov/pubmed/27284428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.841
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados